Neurofilament medium polypeptide (NFM) protein concentration is increased in CSF and serum samples from patients with brain injury

Clinical Chemistry and Laboratory Medicine

Volumn 53, Issue 10, 2015, Pages 1575-1584

  Martínez Morillo, Eduardo ^a,b   Childs, Charmaine ^c   García, Belén Prieto ^b   Álvarez Menéndez, Francisco V ^b   Romaschin, Alexander D ^d   Cervellin, Gianfranco ^e   Lippi, Giuseppe ^e   Diamandis, Eleftherios P ^f,g  

^a MOUNT SINAI HOSPITAL   (Canada)

^b HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^c SHEFFIELD HALLAM UNIVERSITY   (United Kingdom)

^d ST MICHAEL'S HOSPITAL   (Canada)

^e ACADEMIC HOSPITAL OF PARMA   (Italy)

^f MOUNT SINAI HOSPITAL   (Canada)

^g UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

biomarker; brain injury; cerebrospinal fluid; neurofilament; serum; stroke

Indexed keywords

NEUROFILAMENT M PROTEIN; BIOLOGICAL MARKER; NEUROFILAMENT PROTEIN;

ACCURACY; ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CLINICAL EVALUATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ELISA KIT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETER; MIDDLE AGED; MOLECULAR WEIGHT; MULTIPLE TRAUMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; SIZE EXCLUSION CHROMATOGRAPHY; SUBARACHNOID HEMORRHAGE; TANDEM MASS SPECTROMETRY; TRAUMATIC BRAIN INJURY; YOUNG ADULT; BLOOD; BRAIN INJURY; CASE CONTROL STUDY; CEREBROSPINAL FLUID; CEREBROVASCULAR ACCIDENT; REPRODUCIBILITY;

ADULT; BIOMARKERS; BRAIN INJURIES; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROFILAMENT PROTEINS; REPRODUCIBILITY OF RESULTS; STROKE;

EID: 84941194001     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2014-0908     Document Type: Article

References (23)

1. Mondello S, Schmid K, Berger RP, Kobeissy F, Italiano D, Jeromin A, et al. The challenge of mild traumatic brain injury: role of biochemical markers in diagnosis of brain damage. Med Res Rev 2014;34:503-31.
2. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics - 2013 update: a report from the American Heart Association. Circulation 2013;127:e6-245.
3. Schiff L, Hadker N, Weiser S, Rausch C. A literature review of the feasibility of glial fibrillary acidic protein as a biomarker for stroke and traumatic brain injury. Mol Diagn Ther 2012;16:79-92.
4. Schiavi P, Laccarino C, Servadei F. The value of the calcium binding protein S100 in the management of patients with traumatic brain injury. Acta Biomed 2012;83:5-20.
5. Moritz S, Warnat J, Bele S, Graf BM, Woertgen C. The prognostic value of NSE and S100B from serum and cerebrospinal fluid in patients with spontaneous subarachnoid hemorrhage. J Neurosurg Anesthesiol 2010;22:21-31.
6. Brea D, Sobrino T, Blanco M, Cristobo I, Rodriguez-Gonzalez R, Rodriguez-Yanez M, et al. Temporal profile and clinical significance of serum neuron-specific enolase and S100 in ischemic and hemorrhagic stroke. Clin Chem Lab Med 2009;47:1513-8.
7. Martinez-Morillo E, Garcia Hernandez P, Begcevic I, Kosanam H, Prieto Garcia B, Alvarez Menendez FV, et al. Identification of novel biomarkers of brain damage in patients with hemorrhagic stroke by integrating bioinformatics and mass spectrometrybased proteomics. J Proteome Res 2014;13:969-81.
8. Zanier ER, Refai D, Zipfel GJ, Zoerle T, Longhi L, Esparza TJ, et al. Neurofilament light chain levels in ventricular cerebrospinal fluid after acute aneurysmal subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 2011;82:157-9.
9. Kuhle J, Regeniter A, Leppert D, Mehling M, Kappos L, Lindberg RL, et al. A highly sensitive electrochemiluminescence immunoassay for the neurofilament heavy chain protein. J Neuroimmunol 2010;220:114-9.
10. Petzold A, Keir G, Kay A, Kerr M, Thompson EJ. Axonal damage and outcome in subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 2006;77:753-9.
11. Petzold A, Rejdak K, Belli A, Sen J, Keir G, Kitchen N, et al. Axonal pathology in subarachnoid and intracerebral hemorrhage. J Neurotrauma 2005;22:407-14.
12. Prassas I, Diamandis EP. Translational researchers beware! Unreliable commercial immunoassays (ELISAs) can jeopardize your research. Clin Chem Lab Med 2014;52:765-6.
13. Rifai N, Watson ID, Miller WG. Commercial immunoassays in biomarkers studies: researchers beware! Clin Chem 2012;58:1387-8.
14. Martinez-Morillo E, Diamandis A, Romaschin AD, Diamandis EP. Kallikrein 6 as a serum prognostic marker in patients with aneurysmal subarachnoid hemorrhage. PLoS One 2012;7:e45676.
15. Childs C, Martinez-Morillo E, Wai AP, Zu MM, Diamandis A, Diamandis EP. Exploring the relationship between serum biomarkers, acute intracerebral changes and outcome after severe traumatic brain injury (TBI). Clin Chem Lab Med 2013;51:e195-7.
16. Cervellin G, Benatti M, Carbucicchio A, Mattei L, Cerasti D, Aloe R, et al. Serum levels of protein S100B predict intracranial lesions in mild head injury. Clin Biochem 2012;45:408-11.
17. Arlen RK, editor. New research on neurofilament proteins. Hauppauge NY: Nova Science Publishers, Inc, 2007.
18. Liem RK, Messing A. Dysfunctions of neuronal and glial intermediate filaments in disease. J Clin Invest 2009;119: 1814-24.
19. Kuhle J, Gaiottino J, Leppert D, Petzold A, Bestwick JP, Malaspina A, et al. Serum neurofilament light chain is a biomarker of human spinal cord injury severity and outcome. J Neurol Neurosurg Psychiatry [Epub ahead of print 2014 Jun 16]. pii: jnnp-2013-307454. doi: 10.1136/jnnp-2013-307454.
20. Gaiottino J, Norgren N, Dobson R, Topping J, Nissim A, Malaspina A, et al. Increased neurofilament light chain blood levels in neurodegenerative neurological diseases. PLoS One 2013;8:e75091.
21. Cai JY, Lu C, Chen MH, Ba HJ, Chen XD, Lin JH, et al. Predictive value of phosphorylated axonal neurofilament subunit H for clinical outcome in patients with acute intracerebral hemorrhage. Clin Chim Acta 2013;424:182-6.
22. Gresle MM, Liu Y, Dagley LF, Haartsen J, Pearson F, Purcell AW, et al. Serum phosphorylated neurofilament-heavy chain levels in multiple sclerosis patients. J Neurol Neurosurg Psychiatry 2014;85:1209-13.
23. Uhlen M, Oksvold P, Fagerberg L, Lundberg E, Jonasson K, Forsberg M, et al. Towards a knowledge-based Human Protein Atlas. Nat Biotechnol 2010;28:1248-50.